Rare diseases
Investigational molecules
Locations
Back to the Netherlands1 938 clinical trials in Leiden, The Netherlands across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
The NetherlandsStudy on the Effects of AR1001 (Mirodenafil Dihydrochloride) for Patients with Early Alzheimer's Disease
The NetherlandsStudy on the Effects of GV1001 for Patients with Mild to Moderate Alzheimer's Disease
The NetherlandsStudy on the Effects of Semaglutide in Patients with Non-Alcoholic Steatohepatitis (NASH) and Fibrosis Stages 2 or 3
The NetherlandsStudy on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure
The NetherlandsStudy on the Effects of Guselkumab and Golimumab for Patients with Moderate to Severe Ulcerative Colitis
The NetherlandsStudy of Olezarsen (ISIS 678354) in Patients with Severe Hypertriglyceridemia: Testing Effects on Triglyceride Levels
The NetherlandsStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
The NetherlandsStudy of benralizumab compared to placebo for treatment of patients with Hypereosinophilic Syndrome (HES)
The NetherlandsStudy on the Safety and Effectiveness of AMX0035 (Phenylbutyrate and Ursodoxicoltaurine) for Adults with Amyotrophic Lateral Sclerosis (ALS)
The NetherlandsStudy of anifrolumab effectiveness compared to placebo in adults aged 18-70 with systemic sclerosis
The NetherlandsStudy on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on viral infections including trials evaluating vaccines against yellow fever, influenza, and mpox. Research includes assessment of antibody responses and vaccine effectiveness in different populations.
Particular emphasis on preventive strategies and immune response evaluation.
Comprehensive research targeting neurological conditions, including investigations into Parkinson's disease treatments and neural response patterns. Studies examine innovative therapeutic approaches.
Focus on developing targeted therapies and understanding brain mechanisms.
Advanced research in oncology and chronic diseases, including studies on gastric cancer imaging and T-cell lymphoma treatments. Investigations into kidney disease management.
Emphasis on innovative diagnostic techniques and treatment approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
